Pattern of SMARCB1 (INI1) and SMARCA4 (BRG1) in poorly differentiated endometrioid adenocarcinoma of the uterus: analysis of a series with emphasis on a novel SMARCA4-deficient dedifferentiated rhabdoid variant

Wang, 2014, Molecular pathways: SWI/SNF (BAF) complexes are frequently mutated in cancer—mechanisms and potential therapeutic insights, Clin Cancer Res, 20, 21, 10.1158/1078-0432.CCR-13-0280

Shain, 2013, The spectrum of SWI/SNF mutations, ubiquitous in human cancers, PLoS One, 8, e55119, 10.1371/journal.pone.0055119

Klochendler-Yeivin, 2001, Chromatin modifiers and tumor suppression, Biochim Biophys Acta, 1551, M1

Judkins, 2007, Immunohistochemistry of INI1 expression: a new tool for old challenges in CNS and soft tissue pathology, Adv Anat Pathol, 14, 335, 10.1097/PAP.0b013e3180ca8b08

Hollmann, 2011, INI1-deficient tumors: diagnostic features and molecular genetics, Am J Surg Pathol, 35, e47, 10.1097/PAS.0b013e31822b325b

Agaimy, 2014, The expanding family of SMARCB1(INI1)-deficient neoplasia: implications of phenotypic, biological, and molecular heterogeneity, Adv Anat Pathol, 21, 394, 10.1097/PAP.0000000000000038

Hasselblatt, 2011, Nonsense mutation and inactivation of SMARCA4 (BRG1) in an atypical teratoid/rhabdoid tumor showing retained SMARCB1 (INI1) expression, Am J Surg Pathol, 35, 933, 10.1097/PAS.0b013e3182196a39

Dickersin, 1982, Small cell carcinoma of the ovary with hypercalcemia: a report of eleven cases, Cancer, 49, 188, 10.1002/1097-0142(19820101)49:1<188::AID-CNCR2820490137>3.0.CO;2-D

Lamovec, 1995, Familial occurrence of small-cell carcinoma of the ovary, Arch Pathol Lab Med, 119, 523

Kupryjańczyk, 2013, Ovarian small cell carcinoma of hypercalcemic type—evidence of germline origin and SMARCA4 gene inactivation. a pilot study, Pol J Pathol, 64, 238, 10.5114/pjp.2013.39331

Young, 1994, Small cell carcinoma of the ovary, hypercalcemic type. A clinicopathological analysis of 150 cases, Am J Surg Pathol, 18, 1102, 10.1097/00000478-199411000-00004

Jelinic, 2014, Recurrent SMARCA4 mutations in small cell carcinoma of the ovary, Nat Genet, 46, 424, 10.1038/ng.2922

Ramos, 2014, Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4, Nat Genet, 46, 427, 10.1038/ng.2928

Witkowski, 2014, Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type, Nat Genet, 46, 438, 10.1038/ng.2931

2014, vol. 6

Silva, 2006, Association of low-grade endometrioid carcinoma of the uterus and ovary with undifferentiated carcinoma: a new type of dedifferentiated carcinoma?, Int J Gynecol Pathol, 25, 52, 10.1097/01.pgp.0000183048.22588.18

Silva, 2007, Undifferentiated carcinoma of the endometrium: a review, Pathology, 39, 134, 10.1080/00313020601159494

Vita, 2011, Dedifferentiated endometrioid adenocarcinoma of the uterus: a clinicopathologic study of a case, Int J Surg Pathol, 19, 649, 10.1177/1066896911405987

Giordano, 2012, Two cases of low-grade endometrioid carcinoma associated with undifferentiated carcinoma of the uterus (dedifferentiated carcinoma): a molecular study, Pathol Oncol Res, 18, 523, 10.1007/s12253-011-9386-7

Gaertner, 1999, Collision of uterine rhabdoid tumor and endometrioid adenocarcinoma: a case report and review of the literature, Int J Gynecol Pathol, 18, 396, 10.1097/00004347-199910000-00017

Donner, 2007, Mutation of the INI1 gene in composite rhabdoid tumor of the endometrium, Hum Pathol, 38, 935, 10.1016/j.humpath.2006.12.003

Venizelos, 2011, Proximal-type epithelioid sarcoma of the uterine corpus, Histopathology, 58, 321, 10.1111/j.1365-2559.2010.03738.x

Agaimy, 2014, SMARCB1 (INI1)-negative rhabdoid carcinomas of the gastrointestinal tract: clinicopathologic and molecular study of a highly aggressive variant with literature review, Am J Surg Pathol, 38, 910, 10.1097/PAS.0000000000000173

Agaimy, 2015, Pancreatic undifferentiated rhabdoid carcinoma: KRAS alterations and SMARCB1 expression status define two subtypes, Mod Pathol, 28, 248, 10.1038/modpathol.2014.100

Cho, 2006, SMARCB1/INI1 missense mutation in mucinous carcinoma with rhabdoid features, Pathol Int, 56, 702, 10.1111/j.1440-1827.2006.02033.x

Tsai, 2012, Intact INI1 gene region with paradoxical loss of protein expression in AT/RT: implications for a possible novel mechanism associated with absence of INI1 protein immunoreactivity, Am J Surg Pathol, 36, 128, 10.1097/PAS.0b013e3182348cc4

Coira, 2015, Expression inactivation of SMARCA4 by microRNAs in lung tumors, Hum Mol Genet, 24, 1400, 10.1093/hmg/ddu554

Yoshida, 2015, Differential SALL4 immunoexpression in malignant rhabdoid tumours and epithelioid sarcomas, Histopathology, 66, 252, 10.1111/his.12460

Hsueh, 1996, Malignant rhabdoid tumor of the uterine corpus, Gynecol Oncol, 61, 142, 10.1006/gyno.1996.0113

Al-Hussaini, 2008, Uterine neoplasms composed of rhabdoid cells do not exhibit loss of INI1 immunoreactivity and are not related to childhood malignant rhabdoid tumor, Int J Gynecol Pathol, 27, 236